Skip Navigation LinksHome > Professional Development > eLearning > Patient Blood Management in Oncology Patients

Patient Blood Management in Oncology Patients

Please note: AABB reserves the right to make updates to this program.

Thursday, November 8, 2018
2:00 – 3:00 PM (ET) 7:00 – 8:00 PM (GMT)
Master Program Number: 18EL-378 (see program format numbers below under Registration)

Educational Track: Technical/Clinical
Topic: Patient Blood Management
Intended Audience: Director, Hospitals, Hospital Blood Bank, Laboratory Staff, Managers/Supervisors, Medical Directors, Nurses, Perfusionists, Physicians, Resident/Fellow, Technologists, Transfusion Safety Officer
Teaching Level: Intermediate to Advanced

Director/Moderator: Kathy Puca, MD, Medical Director, BloodCenter of Wisconsin, Milwaukee, WI
Speakers: Ehab Atallah, MD, Associate Professor of Medicine, Medical College of Wisconsin, Milwaukee, WI; Mary Fournogerakis, Froedtert Hospital, Milwaukee, WI; Tina Curtis, Executive Director, Cancer Services, Froedtert Hospital, Milwaukee, WI

Learning Objectives

After participating in this educational activity, participants should be able to:

  • Identify the challenges in blood management for the oncology patient
  • Discuss current evidence to guide RBC transfusion practice in oncology patients
  • Describe any strategies for improving RBC or platelet utilization in oncology patients

Program Description

The growing number of patients with cancer and the care and treatment of such patients presents unique challenges for better utilization of blood products. Anemia and thrombocytopenia are common side effects of chemotherapy treatment in oncology patients which can lead to the need for red cell and platelet transfusions. These hematological disorders and treatment regimens can significantly impact the mortality, morbidity, and quality of life for the patient. In this program, the etiologies of anemia and thrombocytopenia in oncology patients and how it differs from medical patients will be discussed as well as potential patient blood management strategies to improve blood utilization in this unique patient population.

Registration

   Program #
Single Viewer: Live Register18EL-378-2031
Single Viewer: On-Demand Register18EL-378-4031
Group Viewing: Live Register18EL-378-6031
Group Viewing: On-Demand Register18EL-378-8031
Group Viewing: Live & On-Demand Register18EL-378-9931

Speaker Biographies

Dr. Ehab Atallah is Associate Professor of Medicine at the Medical College of Wisconsin Division of Hematology and Oncology, specializing in leukemia and myelodysplastic syndromes at Froedtert Hospital. He graduated from Cairo University School of Medicine in 1994, then completed an internal medicine residency in the Cleveland Clinic Health System and a fellowship in hematology/oncology at the Karmanos Cancer Center in Detroit, Michigan, where he also served as Chief Fellow. He then went on to complete a leukemia fellowship at M.D. Anderson Cancer Center in Houston, Texas. Dr. Atallah is board certified in Internal Medicine, Medical Oncology, and Hematology. He has authored numerous publications, including journal articles, meeting abstracts, and a book chapter. In 2007, he received the American Society of Clinical Oncology Foundation Merit Award. His current research interests are treatment of patients with leukemia, myeloproliferative neoplasms and myelodysplastic syndromes.

Tina Curtis, DNP, MBA, RN, NEA-BC has held a variety of progressive nursing leadership roles over the past ten years. She currently serves as the Executive Director for Cancer Services at Froedtert & the Medical College of Wisconsin Clinical Cancer Center. She is responsible for strategic planning, clinical performance, and overall daily operations of the Cancer Service Line. Tina is certified as a Nurse Executive - Advanced, and holds a MSN, MBA, and a Doctorate in Nursing Practice in executive leadership from Marquette University in Milwaukee, Wisconsin.